icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
xRcnQD0yuvkALftP
Listen
